Approval · Notice of Compliance 31216 · 2023
PRO-VALACYCLOVIR: Notice of Compliance 31216
Issued July 13, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31216
- Date
- July 13, 2023
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Labelling Update (to match Licensor)
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRO-VALACYCLOVIR | Not yet assigned | — |
Medicinal ingredients
- VALACYCLOVIR 500 MG per TAB